Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 4/20 | 0.50 |
| ▸ | CTSS | P25774 | 3/20 | 0.50 |
| ▸ | SYK | P43405 | 1/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | KDM4A | O75164 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4000452 | 0.90 | MMP13 (0.46) | CTSKCTSSSYKATMMALT1 | |
| SCHEMBL7837084 | 0.87 | SYK (0.43) | CTSKCTSSSYKMALT1MEN1 | |
| SCHEMBL1429047 | 0.87 | CTSK (0.49) | CTSKCTSSSYKMTNR1AMTNR1B | |
| SCHEMBL16680112 | 0.87 | MAPT (0.54) | CTSKCTSSSYKMTNR1AMTNR1B | |
| SCHEMBL6592966 | 0.87 | CTSK (0.49) | CTSKCTSSSYKMTNR1AMTNR1B | |
| SCHEMBL4583612 | 0.87 | MAPT (0.54) | CTSKCTSSSYKMTNR1AMTNR1B | |
| SCHEMBL16897058 | 0.87 | CTSK (0.49) | CTSKCTSSSYKMTNR1AMTNR1B | |
| SCHEMBL7825061 | 0.87 | SYK (0.43) | CTSKCTSSSYKMALT1MEN1 | |
| SCHEMBL1241387 | 0.86 | AAK1 (0.46) | CTSKCTSSSYKMAPT | |
| SCHEMBL16798314 | 0.86 | SYK (0.48) | CTSKCTSSSYKMTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021044230-A1 | PROCESS FOR THE SYNTHESIS OF THE SODIUM SALT OF 4-[[(LR)-2-[5-(2-FLUORO-3-METHOXYPHENYL)-3-[[2-FLUORO-6-(TRIFLUOROMETHYL)-PHENYL]METHYL]-3,6-DIHYDRO-4-METHYL-2,6-DIOXO-L(2H)-PYRIMIDINYL]-L- PHENYLETHYL]AMINO]-BUTANOIC ACID (ELAGOLIX SODIUM SALT) AND INTERMEDIATES OF SAID PROCESS | INDUSTRIALE CHIMICA S.R.L. (IT) | 2021-03-11 | — | — | WO | disclosed |
| EP-1620432-A1 | NK-2 ANTAGONIST BASIC LINEAR COMPOUNDS AND FORMULATIONS CONTAINING THEM | Menarini Ricerche S.p.A. (IT) | 2006-02-01 | — | — | EP | disclosed |
| WO-2004094412-A1 | NK-2 ANTAGONIST BASIC LINEAR COMPOUNDS AND FORMULATIONS CONTAINING THEM | MENARINI RICERCHE S.P.A. (IT) | 2004-11-04 | — | — | WO | disclosed |
| CN-1160329-C | O-thiocarbamoyl-aminoalkanol compounds, pharmaceutically acceptable salts thereof and process for preparing the same | SK株式会社 | 2004-08-04 | — | — | CN | disclosed |
| EP-1149076-B1 | O-THIOCARBAMOYL-AMINOALKANOL COMPOUNDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PROCESS FOR PREPARING THE SAME | SK CORP (KR) | 2003-10-22 | — | — | EP | disclosed |
| CN-1346346-A | O-thiocarbamoyl-aminoalkanol compounds, pharmaceutically acceptable salts thereof and process for preparing the same | SK CORP (KR) | 2002-04-24 | — | — | CN | disclosed |
| EP-1149076-A1 | O-THIOCARBAMOYL-AMINOALKANOL COMPOUNDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PROCESS FOR PREPARING THE SAME | SK Corporation (KR) | 2001-10-31 | — | — | EP | disclosed |
| WO-2000046191-A1 | O-THIOCARBAMOYL-AMINOALKANOL COMPOUNDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PROCESS FOR PREPARING THE SAME | SK CORPORATION (KR) | 2000-08-10 | — | — | WO | disclosed |
| US-5935997-A | O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically useful salts and process for preparing the same | YUKONG LIMITED (KR) | 1999-08-10 | — | — | US | disclosed |